MYBL2 and breast carcinoma: Included in this region were STK15, which has recently been suggested to be a candidate low-penetrance tumor susceptibility gene in breast cancer [34] and MYBL2, which has been shown to be overexpressed along with STK15 and ZNF217 in prostate cancer [35].